Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media

Daniel N Frank1, Jose Pedrito M Magno2, Karen Joyce S Velasco2

  • 1Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Insights

This study reveals distinct bacterial profiles in middle ear (ME) cholesteatoma compared to other ME tissues in chronic otitis media (OM). Findings offer insights for refining treatments for OM and cholesteatoma, especially in resource-limited settings.

Area of Science:

  • Microbiology
  • Otolaryngology
  • Genomics

Background:

  • Otitis media (OM) is a global health issue, with cholesteatoma being a complication of chronic OM.
  • Cholesteatoma requires surgery but has high recurrence rates, and current antibiotics face resistance.
  • Understanding the middle ear (ME) microbiota is crucial for effective treatment.

Purpose of the Study:

  • To compare the bacterial microbiota of cholesteatoma with other ME tissues in patients with chronic OM.
  • To identify bacterial differences associated with sample type, patient age, and treatment history.

Main Methods:

  • 16S rRNA gene sequencing was used to profile bacteria in 103 ME samples from 53 patients.
  • Respiratory viruses were screened in 115 specimens from 45 patients.
  • Bacterial diversity and abundance were analyzed across different sample types and patient demographics.

Main Results:

  • Significant differences in bacterial profiles (beta-diversity) were found between cholesteatoma and other ME tissues.
  • Patient age correlated with overall microbiota composition and specific bacterial taxa.
  • No respiratory viruses were detected; bacterial biodiversity was lower in cholesteatoma and discharge than in mucosal tissues.

Conclusions:

  • The study identified distinct bacterial communities in cholesteatoma, informing targeted therapies for chronic OM.
  • Findings support the need for microbiota-based treatment strategies, particularly in resource-limited healthcare settings.
  • Age-related microbiota variations offer further avenues for personalized treatment approaches.